PGR and neoplasm: The finding that ESR1 mutations are numerically enriched in luminal A, PIK3CA-mutated and PgR+ tumours, together with the FERGI clinical results, may indicate that highly endocrine sensitive tumours are particularly sensitive to combined targeting of ER and PI3K signalling, a hypothesis that should be explored in future clinical studies.